Camilla Simpson
Directeur/Membre du Conseil chez SPRUCE BIOSCIENCES, INC.
Fortune : - $ au 30/06/2024
Profil
Ms. Camilla V.
Simpson is an Independent Director at GRI Bio, Inc., a President & Managing Member at Rare Strategic LLC, an Independent Director at Spruce Biosciences, Inc. and a Chief Executive Officer & Director at Zehna Therapeutics, Inc. She is on the Board of Directors at GRI Bio, Inc., Dyve Biosciences, Inc., Aristea Therapeutics, Inc., Spruce Biosciences, Inc. and Zehna Therapeutics, Inc. Ms. Simpson was previously employed as a Senior VP & Head-Product Portfolio Development by BioMarin Pharmaceutical, Inc. and a VP-Regulatory Affairs & Business Development by Shire Pharmaceuticals, Inc. She also served on the board at Vallon Pharmaceuticals, Inc. She received her undergraduate degree from Kingston University, an undergraduate degree from National University of Ireland Galway and a graduate degree from the University of London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC.
-.--% | 22/05/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
GRI BIO, INC.
-.--% | 22/04/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Camilla Simpson
| Sociétés | Poste | Début |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 13/11/2017 |
| GRI BIO, INC. | Directeur/Membre du Conseil | 24/04/2023 |
| Rare Strategic LLC | Fondateur | 01/04/2019 |
Dyve Biosciences, Inc.
 Dyve Biosciences, Inc. BiotechnologyHealth Technology Dyve Biosciences, Inc. operates as a research and development company. It focuses on biotech that creates novel therapeutics using proprietary science. The company was founded by Ryan Beal and Rajit Malhotra and is headquartered in Thousand Oaks, CA. | Directeur/Membre du Conseil | 01/12/2020 |
Aristea Therapeutics, Inc.
 Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Directeur/Membre du Conseil | 01/11/2019 |
Zehna Therapeutics, Inc.
 Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zehna Therapeutics, Inc. develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases. The company is based in Cleveland, OH. | Directeur Général | 01/04/2021 |
Anciens postes connus de Camilla Simpson
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/04/2019 |
| GRI BIOPAR | Directeur/Membre du Conseil | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Conseiller Juridique Général | - |
Formation de Camilla Simpson
| University of London | Graduate Degree |
| Kingston University | Undergraduate Degree |
| National University of Ireland Galway | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| GRI BIO, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Aristea Therapeutics, Inc.
Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Health Technology |
Dyve Biosciences, Inc.
Dyve Biosciences, Inc. BiotechnologyHealth Technology Dyve Biosciences, Inc. operates as a research and development company. It focuses on biotech that creates novel therapeutics using proprietary science. The company was founded by Ryan Beal and Rajit Malhotra and is headquartered in Thousand Oaks, CA. | Health Technology |
| Rare Strategic LLC | |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
Zehna Therapeutics, Inc.
Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zehna Therapeutics, Inc. develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases. The company is based in Cleveland, OH. | Health Technology |
